Ramsingh Davinder, Hu Huayong, Yan Manshu, Lauer Ryan, Rabkin David, Gatling Jason, Floridia Rosario, Martinez Mckinzey, Dorotta Ihab, Razzouk Anees
Department of Anesthesiology, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.
Department of Cardiothoracic Surgery, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.
J Clin Med. 2021 Jan 21;10(3):400. doi: 10.3390/jcm10030400.
Cardiac surgery patients are at increased risk for post-operative complications and prolonged length of stay. Perioperative goal directed therapy (GDT) has demonstrated utility for non-cardiac surgery, however, GDT is not common for cardiac surgery. We initiated a quality improvement (QI) project focusing on the implementation of a GDT protocol, which was applied from the immediate post-bypass period into the intensive care unit (ICU). Our hypothesis was that this novel GDT protocol would decrease ICU length of stay and possibly improve postoperative outcomes.
This was a historical prospective, QI study for patients undergoing cardiac surgery requiring cardiopulmonary bypass (CPB). Integral to the QI project was education towards all associated providers on the concepts related to GDT. The protocol involved identifying patient specific targets for cardiac index and mean arterial pressure. These targets were maintained from the post-CPB period to the first 12 h in the ICU. Statistical comparisons were performed between the year after GDT therapy was launched to the last two years prior to protocol implementation. The primary outcome was ICU length of stay.
There was a significant decrease in ICU length of stay when comparing the year after the protocol initiation to years prior, from a median of 6.19 days to 4 days (2017 vs. 2019, < 0.0001), and a median of 5.88 days to 4 days (2018 vs. 2019, < 0.0001). Secondary outcomes demonstrated a significant reduction in total administered volumes of inotropic medication(milrinone). All other vasopressors demonstrated no differences across years. Hospital length of stay comparisons did not demonstrate a significant reduction.
These results suggest that an individualized goal directed therapy for cardiac surgery patients can reduce ICU length of stay and decrease amount of inotropic therapy.
心脏手术患者术后并发症风险增加,住院时间延长。围手术期目标导向治疗(GDT)已证明对非心脏手术有用,然而,GDT在心脏手术中并不常见。我们启动了一项质量改进(QI)项目,重点是实施GDT方案,该方案从体外循环后即刻应用至重症监护病房(ICU)。我们的假设是,这种新型GDT方案将缩短ICU住院时间,并可能改善术后结局。
这是一项针对需要体外循环(CPB)的心脏手术患者的历史性前瞻性QI研究。QI项目的一个组成部分是对所有相关医护人员进行与GDT相关概念的教育。该方案包括确定患者特定的心脏指数和平均动脉压目标。这些目标在CPB后时期至ICU的最初12小时内维持。在GDT治疗开始后的年份与方案实施前的最后两年之间进行统计比较。主要结局是ICU住院时间。
将方案启动后的年份与之前的年份进行比较时,ICU住院时间显著缩短,从中位数为6.19天降至4天(2017年与2019年相比,<0.0001),以及从中位数为5.88天降至4天(2018年与2019年相比,<0.0001)。次要结局显示,血管活性药物(米力农)的总给药量显著减少。所有其他血管升压药在各年份之间均无差异。住院时间比较未显示出显著缩短。
这些结果表明,针对心脏手术患者的个体化目标导向治疗可缩短ICU住院时间并减少血管活性治疗的用量。